BD MAX™ MDR-TB - Indonesia BPOM Medical Device Registration
BD MAX™ MDR-TB is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303420667. The device is manufactured by GENEOHM SCIENCES CANADA INC. from Canada, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. BECTON DICKINSON INDONESIA.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Risk Classification
Product Class
Kelas : 2
Manufacturer
GENEOHM SCIENCES CANADA INC.Country of Origin
Canada
Authorized Representative
PT. BECTON DICKINSON INDONESIAAR Address
Sampoerna Strategic Square South Tower 20th Floor Jl. Jend. Sudirman Kav 45-46
Registration Date
Jan 20, 2025
Expiry Date
Dec 21, 2028
Product Type
Serological Reagents
Nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex (MTB-complex) and the genetic mutations associated with MTB-complex antibiotic resistance in respiratory specimens (kit & cair)
Invitro Diagnostics
BD Gravity IV Set with ARD Technology and AutoPrime
CAREFUSION BH 335 D.O.O CAZIN
BD BBL™ Sensi-Disc™ CEFTRIAXONE 30 µg
BECTON DICKINSON CARIBE LTD.
BD BBL™ Sensi-Disc™ Levofloxacin 5 µg
BECTON DICKINSON CARIBE LTD.
BD Leucocount™ Kit
BECTON DICKINSON CARIBE, LTD.
BD Onclarity™ HPV Assay Reagent Pack
BECTON, DICKINSON AND COMPANY
AST-Reagent Kit
MERLIN DIAGNOSTIKA GMBH
BD FC Beads 7-Color Kit
BECTON DICKINSON CARIBE, LTD.
BD BBL Sensi-Disc Colistin 10 µg
BECTON DICKINSON CARIBE LTD.
BD POSIFLUSH SP Syringe
BECTON DICKINSON, S.A.
BD BBL™ Sensi-Disc™ CHLORAMPHENICOL 30 µg
BECTON DICKINSON CARIBE LTD.

